ProCE Banner Activity

Safe and Effective Type 2 Diabetes Management in Older Adults: FAQs

Clinical Thought

In this commentary, an expert answers audience questions from the webinar “A Balancing Act: Strategies for Safe and Effective Type 2 Diabetes Management in Older Adults."

Released: September 13, 2022

Expiration: September 12, 2023

No longer available for credit.



Richard E. Pratley

Richard E. Pratley, MD

Samuel E. Crockett Chair in Diabetes Research
Medical Director
AdventHealth Diabetes Institute
Senior Investigator and Diabetes Program Lead
AdventHealth Translational Research Institute
Adjunct Professor of Medicine
Johns Hopkins University School of Medicine
Orlando, Florida


This activity is supported by an educational grant from Sanofi US.


Sanofi US

Target Audience

NPs and PAs that practice in endocrinology


Richard E. Pratley, MD: researcher: Hanmi Pharmaceuticals, Metavention, Novo Nordisk, Poxel SA, Sanofi; consultant/advisor/speaker: Bayer, Corcept Therapeutics, Dexcom, Gasherbrum Bio, Hanmi Pharmaceuticals, Hengrui USA, Merck, Metavention, Novo Nordisk, Pfizer, Poxel SA, Rivus Pharmaceuticals, Sanofi, Scohia Pharma, Sun Pharmaceuticals

None of the members of the Planning Committee or PCE staff have any relevant financial relationships to disclose.



Additional Information

Program Medium

This program has been made available online.